๐ฅ In questo video il Dott. Andi Nuredini, SC Neurologia, Azienda Ospedaliero-Universitaria di Modena e Universitร degli Studi di Modena e Reggio Emilia, spiega perchรฉ il neurologo รจ lo specialista di tutto il sistema nervoso, non solo del cervello.
๐ซฅPaper Published!
Excited to share our research, "The Psychological Burden of Neuromuscular Diseases: A Narrative Review of Anxiety, Depression, Coping, and Quality of Life", published in Muscles!
๐ทRead more here: https://t.co/eqKxDYAiVe
#neuromuscular#diseases#anxiety
CoMPaSS-NMD at the 30th Annual Congress of the @WorldMuscleSociety โ Vienna, October 7โ11, 2025
Our experts on the stage:
๐ค Andi Nuredini from Universitร degli Studi di Modena e Reggio Emilia,
๐Michal Marczyk, Marek Socha, and Aleksandra Suwalska from Politechnika ลlฤ ska
What if a disease isn't caused by a single faulty gene, but by a "two-hit" combo?
๐งฌ๐ฌ Our latest blog post dives into the emerging concept of #digenic#inheritance in #muscle#diseases.
๐ Find out more:
https://t.co/yuXAHjYGCu
In one week, we're kicking off the 2025 webinar series for the CoMPaSS-NMD Young Investigator Programme.
You can register here: https://t.co/K22RhgGhoh
We hope to see you there!
The future of healthcare isn't AI vs. humans; it's about humans who master AI. Today's CoMPaSS-NMD editorial on ACTA Myologica highlights this, focusing on how #AI is revolutionizing neuromuscular disorder diagnosis & management.
https://t.co/c7huFREYr5
๐ท Exciting News from CoMPaSS-NMD! ๐ท
We're happy to share the foundational architecture of the CoMPaSS-NMD ATLAS platform developed by @FinconsGroup!
Visit the ATLAS webpage for more updates as we finalize and exploit this powerful platform: https://t.co/bc1G4vG7x1
The 2nd CoMPaSS-NMD seminar is coming soon.
TOPIC: Omics analysis of skeletal muscle homeostasis under normal and pathological conditions
DATE: 11 March 2025
TIME: 9:00 CET
VENUE: in person or online
For more details and registration visit the page: https://t.co/qG8er0nAqI
Did you know your genetic makeup can significantly influence your susceptibility to diseases like neuromuscular disorders?
To know more, read our new article:
https://t.co/a7KuDkecnV
We are thrilled to launch the first issue of our project newsletter, keeping you informed about the exciting progress of CoMPaSS-NMD.
READ THE FIRST NEWSLETTER: https://t.co/rsY0jXBqIu...
Subscribe to receive our Newsletters: https://t.co/KDn3NYOSjR...
The 2024 Nobel Prizes in Physics and Chemistry and the CoMPaSS-NMD project have a surprising connection: #Artificial_Intelligence
Read our new article on the CoMPaSS-NMD website: https://t.co/9P2gW1alZC
Images credits: Niklas Elmehed ยฉ Nobel Prize Outreach.
Vi ricordiamo gli appuntamenti di oggi con SIgN al congresso della @sinneurologia:
- ๐Riunione SIgN, Sala Sardegna ore 14.30
- ๐ง Clinical Grand Rounds in Neurologia, Auditorium ore 17.30
- ๐ณ๏ธ Votazioni online per il rinnovo del consiglio direttivo SIN
Non mancate!
Today, we approved the first gene therapy for the treatment of patients 4-5 years of age with Duchenne muscular dystrophy (DMD) with a confirmed mutation in the DMD gene who do not have a pre-existing medical reason why they can't receive this therapy. https://t.co/AA02wAusjK
Il consiglio si rinnova! Il 12-13-14 maggio si sono svolte le elezioni per il consiglio direttivo di #SIgN, che hanno portato all'elezione di 4 nuovi consiglieri Junior! Facciamo anche gli auguri al nuovo gruppo di coordinamento! #neurologia#sezionegiovani